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INTRODUCTION 
Haemophilus influenzae (Hi) is a Gram-negative 
bacterium that is exclusive to the upper respiratory 
tract of humans. Hi strains possessing an extracellular 
polysaccharide capsule, particularly serotype b H. 
influenzae (Hib), are responsible for invasive 
infections such as bacterial meningitis and 
bacteremia. Strains without a polysaccharide capsule, 
known as non-typable H. influenzae (NTHi), are 
responsible for ear infections and other diseases in 
children. Disease caused by Hib infections has 
become rare in developed countries since the 
introduction of a conjugate serogroup b vaccine. 
However disease caused by NTHi and other Hi 
serotypes, particularly type a Hi, has increased [1]. 
To prevent disease caused by non-vaccine Hi 
serotypes novel vaccines will need to be produced 
that are effective against multiple serotypes of Hi, 
including NTHi 
It has been demonstrated that transferrin binding 
protein B (TbpB) in the porcine pathogen, 
Actinobacillus pleuropneumoniae (Ap), is essential 
for survival and causing disease in a porcine infection 
model [2]. TbpB is now being developed as a vaccine 
target. Since Ap and Hi are both host-restricted 
bacteria in the Pasteurellaceae family, we consider 
TbpB in Hi as a logical vaccine target. . 
METHODS 
To investigate the diversity of TbpBs in Hi, the tbpB 
genes from a collection of 43 unique Hi strains from 
Canada, the United States and England were 
sequenced. These strains represent a wide diversity of 
clinical manifestations and serotypes, allowing us to 
investigate the diversity of the tbpB gene in Hi. 
Phylogenetic analysis was undertaken to cluster the 
tbpB genes based on sequence similarity. These 
analyses of the relationships between phylogenetic 
clusters and clinical/epidemiological information 
explore the prevalence and diversity of transferrin 
receptor genes in Hi. 
RESULTS 
Analysis of the data showed that the sequences of the 
various TbpB proteins clustered independently of 
serotype. This shows that development of a TbpB-
based vaccine would logically target all serotypes and 
non-typeable strains, rather than having to develop a 
series of vaccines for the different groups. The 
analysis of the multiple sequence alignments 
generated from the TbpB sequences showed higher 
conservation in the C lobe of TbpB than the N lobe.  
Of particular interest was the observation made while 
mapping conserved regions of the sequence 
alignments to a structural model of TbpB that a 
region exists on the N lobe of TbpB which is highly 
conserved in all Hi strains sequenced.  
 
DISCUSSION AND CONCLUSIONS 
The immunogenic properties of this conserved region 
of TbpB have not yet been investigated. The number 
of strains sequenced was also limited and they were 
only of serotype B and NTHi. More diverse Hi strains 
need to be sequenced to confirm the conservation of 
TbpB across all serotypes and further studies still 
need to be completed to confirm that these conserved 
regions are actually immunogenic. However this 
study has shown that TbpB has potential to be used as 
a target for a new cross protective Hi vaccine. 
REFERENCES 
1.  Rubach, M et al. Emerg Infect Dis. 17: 1645-     
1650, 2011.  
2. Balts, N et al. FEMS Microbiol Lett. 209: 283-287, 
2002
 
